Cancer Immunotherapy Research Engineer
Helse Sør-øst RHF
Obtenez une réponse de cet employeur
Votre CV et votre lettre de motivation, adaptés exactement à ce que l’employeur recherche.
Avantages offerts par ce poste
Résumé du poste
Oslo University Hospital is seeking a research engineer (spesialingeniør) in molecular and cell biology for the Targeted Therapies and Immunomodulation group led by Prof. Mouldy Sioud within the Department of Cancer Immunology.
The role focuses on developing cancer therapeutics, including antibodies, derivatives, and modified mRNA vaccines, using in vitro screening and cellular techniques. The position offers exposure to basic and translational research aiming to identify novel targets and
Qualifications
- Master's degree in molecular biology, cell biology, biotechnology, immunology, or a related field.
- Practical experience in molecular and cellular biology, including cell culture, transfection, cloning, and protein analysis.
- Experience with flow cytometry, immunoprecipitation, protein purification, and/or immunological techniques is highly desirable.
- Good communication skills in English and the ability to work independently and collaboratively.
Responsabilités
- Contribute to development of cancer therapeutics such as antibodies, antibody derivatives, and modified mRNA vaccines.
- Identify novel targets and strategies for cancer immunotherapy through in vitro screening and translational research.
- Collaborate with interdisciplinary teams to advance basic and translational research in the target therapies group.
Connaissances
Formation
Description du poste
Oslo University Hospital is seeking a research engineer (spesialingeniør) in molecular and cell biology for the Targeted Therapies and Immunomodulation group led by Prof. Mouldy Sioud within the Department of Cancer Immunology.
The role focuses on developing cancer therapeutics, including antibodies, derivatives, and modified mRNA vaccines, using in vitro screening and cellular techniques. The position offers exposure to basic and translational research aiming to identify novel targets and
'/%3e%3cpath%20d='M101.744%2012.4726L102.894%2016.1947L99.0021%2013.2201L101.744%2012.4726ZM105.3%208.40937H100.488L99.0026%203.59473L97.5116%208.41047L92.7%208.40385L96.5965%2011.3834L95.1055%2016.1942L99.0021%2013.2196L101.408%2011.3834L105.3%208.40992V8.40937Z'%20fill='white'/%3e%3cdefs%3e%3clinearGradient%20id='paint0_linear_5593_1381'%20x1='90'%20y1='9.44471'%20x2='99'%20y2='9.44471'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20stop-color='%2300AD70'/%3e%3cstop%20offset='0.998594'%20stop-color='%2300B67A'/%3e%3cstop%20offset='1'%20stop-color='%23DCDCE6'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e){kind=small}
